Circadian clock disruptions and the risk of cancer.

Circadian clock disruptions and the risk of cancer.

Item
http://www.wikidata.org/entity/Q38052599
Case-control study of the PERIOD3 clock gene length polymorphism and colorectal adenoma formationCase-control study of breast cancer in India: Role of PERIOD3 clock gene length polymorphism and chronotypeHepatitis B virus X protein disrupts the balance of the expression of circadian rhythm genes in hepatocellular carcinomaRoles of F-box proteins in cancerIntegrative analysis of circadian transcriptome and metabolic network reveals the role of de novo purine synthesis in circadian control of cell cycleNon-24-Hour Sleep-Wake Disorder Revisited - A Case Study.The circadian timing system in clinical oncology.Potential pleiotropic beneficial effects of adjuvant melatonergic treatment in posttraumatic stress disorder.MiR-29a/b/c regulate human circadian gene hPER1 expression by targeting its 3'UTR.Case-control study of candidate gene methylation and adenomatous polyp formation.Pay attention to evening owls.CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome.
P2860

Circadian clock disruptions and the risk of cancer.

Item
http://www.wikidata.org/entity/Q38052599
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Circadian clock disruptions and the risk of cancer.
@en
type
label
Circadian clock disruptions and the risk of cancer.
@en
prefLabel
Circadian clock disruptions and the risk of cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Circadian clock disruptions and the risk of cancer.
@en
P2093
P2860
P304
P31
P356
10.3109/07853890.2012.727018
P407
P433
P478
P50
P577
P698
P921